-
NCP1249DD65R2G: Advancing Power Factor Correction for Energy-Efficient Electronics | ChipsXNCP1249DD65R2G: Advancing Power Factor Correction for Energy-Efficient Electronics | ChipsX
-
XC7Z030-1SBG485C: Enhancing Embedded Systems with FPGA Power | ChipsXXC7Z030-1SBG485C: Enhancing Embedded Systems with FPGA Power | ChipsX
-
AD9573ARUZ-RL7: Pioneering Precision Timing Solutions for Next-Generation Systems | ChipsXAD9573ARUZ-RL7: Pioneering Precision Timing Solutions for Next-Generation Systems | ChipsX
-
开启移动补能新时代 创维汽车超充车型亮相2024北京车展开启移动补能新时代 创维汽车超充车型亮相2024北京车展
-
XC2VP4-6FFG672I: Unleashing Performance in FPGA-Based Embedded Systems | ChipsXXC2VP4-6FFG672I: Unleashing Performance in FPGA-Based Embedded Systems | ChipsX
-
汽车商城管理平台:智慧之选,驾驭未来汽车商城管理平台:智慧之选,驾驭未来
-
拓展全球业务?CE Channel精准匹配全球合作伙伴!拓展全球业务?CE Channel精准匹配全球合作伙伴!
-
CE Channel:开启国际市场之门,助您发掘全球商机!CE Channel:开启国际市场之门,助您发掘全球商机!
-
寻找最佳合作伙伴?CE Channel为您量身打造国际化解决方案!寻找最佳合作伙伴?CE Channel为您量身打造国际化解决方案!
-
EP2S60F1020I5: Revolutionizing Embedded Systems with High-Performance FPGA Solutions | ChipsXEP2S60F1020I5: Revolutionizing Embedded Systems with High-Performance FPGA Solutions | ChipsX
24h快讯
-
著名海派画家沈三草迎新春作品选沈三草简介 沈三草原名沈从斌1958年生于浙江温岭,祖籍浙江绍兴。少年时的中国画启蒙老师为温州画家石奇、戴学正、方介堪先生2025-01-27
-
小豚品牌闪耀登场携手《济公陪你过大年》启动仪式,共赴味觉与文化盛宴在这个充满希望与创新的时代,每一个细微之处都蕴藏着无限可能,尤其是在美食与文化交融的领域。近日,一场别开生面的盛事——中国首部贺岁档短视频剧《济公陪你过大2025-01-27
-
花鸟画名家林涛先生新作赏析林涛,1968年生,祖籍福建莆田,自幼随父亲—国画家林金定学画。现为中国职工美术家协会副主席,中国美术家协会第九届、第十届理事,中国美协中国画艺术委员会副秘书长,中2025-01-27
-
新疆卫视首档明星冰雪体验慢综艺节目《怦然“新”动的冬天》定档1月31日1 月 31 日,新疆卫视首档明星冰雪体验慢综艺节目《怦然“新”动的冬天》即将欢乐开播,带你领略新疆冬日的独特魅力,感受银白世界里的热血与温情。 节目未播先火,2025-01-27
-
大象与年轻人趣味迎蛇年,携京东健康推出礼盒引流潮流风尚年关将至,在挑战面前寄托新一年的希望 随着农历新年的脚步越来越近,人们都在为年终的目标和计划忙碌着,为过去一年的辛勤工作画上圆满的句号。这是一个总结经验、规2025-01-27
-
香港美术家协会副会长——冉爱兰简介 冉爱兰,女,郑州市人。现为中国美术家协会会员、河南省书法家协会会员、郑州市书法家协会会员,郑州市美术家协会会员,香港美术家协会副会长。擅长国2025-01-27
-
Politecnico di Torino’s EU-Italy Energy Days: Nuclear, Hydrogen and alternative fuels were the coreMario Draghi was awarded the international "PoliTO Foresight and Innovation" prize TURIN, Italy, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Th2025-01-27
-
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a ProAlvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, an2025-01-27